Stock Exchange Announcements
Positive outcome reached at 16 weeks for Avexa's ATC phase III trial
Update to 2009 capital raising effort
Avexa signs option agreement with Tibotec
Rights Issue completed - $17m raised
All Other AnnouncementsLatest Company Presentations/Reports
ABN AMRO Research Report May 2009
Company Presentation April 2009
